IMvigor130: Efficacy and safety from a phase III study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs placebo + PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)

Enrique Grande, Matt D. Galsky, J.Á. Arranz Arija, Maria De Santis, Ian D. Davis, U.F.F. De Giorgi, Marina Mencinger, Eiji Kikuchi, Xavier García del Muro, Mustafa Özgüroğlu,

Annals of Oncology · 2019 · 39 citations · 0 references

DOIFull text

Open access

Concepts